BioCardia BCDA
NASDAQ BCDA
$0.98 +0.00 (+0.05%)
As of: Oct 22, 2026 · 9:36 AM EDT

BioCardia (BCDA) Short-term Investments (2017)

Updated

BioCardia (BCDA) reported Short-term Investments of $1.8 million for Q3 2017, up 0.2% from the prior quarter.

Analysis

BioCardia (BCDA) Short-term Investments (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,152.37 Bn 1,120.96 Bn 19.71 Bn
2 Johnson & Johnson 628.86 Bn 547.39 Bn 17.26 Bn
3 AbbVie 500.37 Bn 473.48 Bn 12.70 Bn
4 Merck 374.01 Bn 328.39 Bn 12.21 Bn
5 Novartis Ag 300.56 Bn 264.55 Bn 11.24 Bn
6 Astrazeneca 263.92 Bn 237.60 Bn 12.86 Bn
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn
8 Gilead Sciences 192.21 Bn 166.40 Bn 6.22 Bn
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn
10 BioCardia 11.89 Mn -977,526.60 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 1.80 Mn
Jun 30, 2017 1.80 Mn
API Access

BioCardia Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=BCDA&period=max&api_key=YOUR_API_KEY